Literature DB >> 1255476

Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.

A L Misra, R B Pontani, N L Vadlamani, S J Mulé.   

Abstract

A sensitive method is described for the estimation of [14C]naloxone in biological materials. After a 1 mg/kg s.c. dose of [14C]naloxone to male Wistar rats, mean peak levels of drug in brain (506 ng/g) and plasma (119 ng/ml) were attained within 15 minutes. No persistence of drug in brain was observed at this dose. After a 10 mg/kg s.c. dose, the peak levels of naloxone in brain and plasma were 4.31 mug/g and 1.27 mug/ml, respectively, and extensive localization of extractable free drug and its minor metabolite, naloxol, occurred in tissues with high levels in kidney, spleen, lung, heart, skeletal muscle and somewhat lower concentration in the liver. The T1/2 of naloxone and nalorphine in rat brain and plasma with 1 and 10 mg/kg s.c. doses was 0.4 hour. With a 10 mg/kg dose, significant amounts of radioactivity persisted in tissues but not in plasma 96 hours after injection. The brain/plasma ratios and degree of plasma-protein binding were significantly higher for naloxone as compared to nalorphine. The amounts of free naloxone excreted as a percentage of the dose in urine and feces 96 hours after injection of the 10 mg/kg s.c. dose were 4.1 and 3.9 (for nalorphine 4.7 and 8.3); conjugated drug 15.4 and 1.2 (for nalorphine 13 and 0.9); total radioactivity 43.3 and 20.9 (for nalorphine 34.8 and 19.2), respectively. Naloxone-3-glucuronide (major), 3-sulfate (minor), naloxol and conjugated naloxol (minor), 7,8-dihydro-14-hydroxynormorphine, 7,8-dihydro-14-hydroxynormorphine and their conjugates were shown to be the metabolites of naloxone. In addition, tentative evidence was obtained for two polar hydroxylated metabolites (with hydroxylation presumably in the 17-side chain or in position 2 of the aromatic nucleus). 7,8-Dihydro-14-hydroxynormorphinone and 2-polar metabolites were also observed in brain. Rapid metabolism of naloxone and rapid elimination are important factors in its short duration of action. Possible relevance of these observations on differential antagonistic properties of these two antagonists are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255476

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.

Authors:  P L Wood; C Pilapil; M Thakur; J W Richard
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

Review 2.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

Review 3.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

4.  Porcine pituitary peptides with opiate-like activity: partial purification and effects in the rat after intraventricular injection.

Authors:  H Teschemacher; J Bläsig; W Kromer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-09       Impact factor: 3.000

5.  The antinociceptive action of etorphine in the dorsal horn is due to a direct spinal action and not to activation of descending inhibition.

Authors:  S L Clark; R W Ryall
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

6.  Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.

Authors:  Takae Ibuki; Martin Marsala; Takashi Masuyama; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers.

Authors:  Azmi F Nasser; Christian Heidbreder; Yongzhen Liu; Paul J Fudala
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

8.  Opioids and sexual behavior in the male rabbit: the role of central and peripheral opioid receptors.

Authors:  A Agmo; R G Paredes; J L Contreras
Journal:  J Neural Transm Gen Sect       Date:  1994

9.  Influence of naloxone upon motor activity induced by psychomotor stimulant drugs.

Authors:  D N Jones; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

10.  Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.

Authors:  A Agmo; J Rojas; P Vázquez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.